Authors: Juengling, FD Ebert, D Gut, O Engelbrecht, MA Rasenack, J Nitzsche, EU Bauer, J Lieb, K

Citation: Fd. Juengling et al., Prefrontal cortical hypometabolism during low-dose interferon alpha treatment, PSYCHOPHAR, 152(4), 2000, pp. 383-389

Authors: Schories, M Peters, T Rasenack, J

Citation: M. Schories et al., Isolation, characterization and biological significance of hepatitis B virus mutants from serum of a patient with immunologically negative HBV infection, J HEPATOL, 33(5), 2000, pp. 799-811

Authors: Kamal, SM Madwar, MA Peters, T Fawzy, R Rasenack, J

Citation: Sm. Kamal et al., Interferon therapy in patients with chronic hepatitis C and schistosomiasis, J HEPATOL, 32(1), 2000, pp. 172-174

Authors: Zeuzem, S Feinman, SV Rasenack, J Heathcote, EJ Lai, MY Gane, E O'Grady, J Reichen, J Diago, M Lin, A Hoffman, J Brunda, MJ

Citation: S. Zeuzem et al., Peginterferon alfa-2a in patients with chronic hepatitis C, N ENG J MED, 343(23), 2000, pp. 1666-1672

Authors: Jantschek, G Zeitz, M Pritsch, M Wirsching, M Klor, HU Studt, HH Rasenack, J Deter, HC Riecken, EO Feiereis, H Keller, W

Citation: G. Jantschek et al., Effect of psychotherapy on the course of Crohn's disease - Results of the German prospective multicenter psychotherapy treatment study on Crohn's disease, SC J GASTR, 33(12), 1998, pp. 1289-1296